Sales from the company’s medical device business increased 6.4 percent in the second quarter, reaching a total of $1.37 billion. Net sales rose by 3.2 percent to $5.33 billion, surpassing Wall Street’s prediction of $5.24 billion.
Abbott’s medical device division produces products for heart, diabetes and eye patients.
Recently, Abbott shared a definitive agreement to acquire St. Paul, Minn.-based device company St. Jude Medical for $25 billion. The deal is expected to close by the end of the year.
More articles on medical devices:
This headband isn’t for fashion— it offers migraine relief
Zimmer Biomet acquires Medtech SA
FDA approves Syneron Candela’s weight loss device
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
